{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:47:33Z","timestamp":1786996053486,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T00:00:00Z","timestamp":1463097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Brasileira de Reumatologia (English Edition)"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.rbre.2016.05.003","type":"journal-article","created":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T03:27:47Z","timestamp":1464751667000},"page":"590-595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Three cases of anti-TNF induced myositis and literature review"],"prefix":"10.1016","volume":"57","author":[{"given":"Orhan","family":"Zengin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Erkut","family":"Onder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samet","family":"Alkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gezmi\u015f","family":"Kimyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nergis","family":"H\u00fcseynova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep Han\u0131m","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fcnyamin","family":"K\u0131sac\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Mesut","family":"Onat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbre.2016.05.003_bib0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00000441-200302000-00005","article-title":"New indications for treatment of chronic inflammation by TNF-alpha blockade","volume":"325","author":"Reimold","year":"2003","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.rbre.2016.05.003_bib0010","first-page":"893","article-title":"TNF alfa modulators in the treatment of RA","volume":"82","author":"Kochbati","year":"2004","journal-title":"Tunis Med"},{"key":"10.1016\/j.rbre.2016.05.003_bib0015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10067-009-1370-1","article-title":"Etanercept-induced anti-Jo-1-antibody-positive polymyositis in a patient with RA: a case report and review of the literature","volume":"29","author":"Ishikawa","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rbre.2016.05.003_bib0020","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/rheumatology\/keg388","article-title":"Polymyositis associated with infliximab treatment for RA","volume":"42","author":"Musial","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rbre.2016.05.003_bib0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard.62.suppl_2.ii30","article-title":"Survival during treatment with tumour necrosis factor blocking agents in RA","volume":"62","author":"Flendrie","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rbre.2016.05.003_bib0030","doi-asserted-by":"crossref","first-page":"R666","DOI":"10.1186\/ar1724","article-title":"Dermatological conditions during TNF-alpha-blocking therapy in patients with RA: a prospective study","volume":"7","author":"Flendrie","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rbre.2016.05.003_bib0035","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3109\/s10165-006-0523-1","article-title":"Polymyositis associated with infliximab treatment for RA","volume":"16","author":"Urata","year":"2006","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.rbre.2016.05.003_bib0040","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/art.22358","article-title":"Evolution of dermatomyositis during therapy with a tumor necrosis factor \u03b1 inhibitor","volume":"55","author":"Hall","year":"2006","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rbre.2016.05.003_bib0045","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/03009740701281293","article-title":"Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma","volume":"36","author":"Liozon","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.rbre.2016.05.003_bib0050","first-page":"2074","article-title":"Neuromuscular involvement in rheumatic patients treated with anti-TNF therapy\u2014three examples","volume":"35","author":"Kiltz","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rbre.2016.05.003_bib0055","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.berh.2008.09.008","article-title":"Autoimmune diseases induced by TNF targeted therapies","volume":"22","author":"Ramos-Casals","year":"2008","journal-title":"Best Pract Res"},{"key":"10.1016\/j.rbre.2016.05.003_bib0060","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3899\/jrheum.091413","article-title":"Dermatomyositis during adalimumab therapy for RA","volume":"37","author":"Brunasso","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rbre.2016.05.003_bib0065","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/archdermatol.2010.142","article-title":"Tumor necrosis factor inhibitor-associated dermatomyositis","volume":"146","author":"Klein","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.rbre.2016.05.003_bib0070","first-page":"240","article-title":"Antisynthetase (anti PL-7 antibody) syndrome presenting as a skin rash and exacerbation of interstitial pneumonia during treatment for RA","volume":"48","author":"Ishiguro","year":"2010","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"10.1016\/j.rbre.2016.05.003_bib0075","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10067-010-1666-1","article-title":"A case of antisynthetase syndrome in a RA patient with anti-PL-12 antibody following treatment with etanercept","volume":"30","author":"Ishikawa","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rbre.2016.05.003_bib0080","first-page":"192","article-title":"Anti-tumor necrosis factor inhibitor therapy-induced dermatomyositis and fasciitis","volume":"39","author":"Riolo","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rbre.2016.05.003_bib0085","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/jamadermatol.2013.5220","article-title":"Dermatomyositis induced by anti-tumor necrosis factor in a patient with juvenile idiopathic arthritis","volume":"149","author":"Liu","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.rbre.2016.05.003_bib0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/08916930400022640","article-title":"Anti-Jo-1 antibodies","volume":"38","author":"Zampieri","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.rbre.2016.05.003_bib0095","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11926-003-0052-2","article-title":"The role of Jo-1 in the immunopathogenesis of polymyositis: current hypotheses","volume":"5","author":"Ascherman","year":"2003","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.rbre.2016.05.003_bib0100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/cei.12445","article-title":"Cytokines in immune mediated inflammatory myopathies: cellular sources, multipl actions and therapeutic implications","volume":"178","author":"Moran","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rbre.2016.05.003_bib0105","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/j.lpm.2010.12.012","article-title":"Therapy of polimyositis and dermatomyositis","volume":"40","author":"Marie","year":"2011","journal-title":"Presse Med"},{"key":"10.1016\/j.rbre.2016.05.003_bib0110","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jbspin.2010.04.007","article-title":"Treatment of inflammatory muscle disease in adults","volume":"77","author":"Tournadre","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.rbre.2016.05.003_bib0115","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases","volume":"86","author":"Ramos-Casals","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rbre.2016.05.003_bib0120","first-page":"1802","article-title":"Use of etanercept in the treatment of dermatomyositis: a case series","volume":"33","author":"Iannone","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rbre.2016.05.003_bib0125","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/art.10302","article-title":"The relationship of serum infliximab concentrations to clinical improvement in RA: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial","volume":"46","author":"St Clair","year":"2002","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rbre.2016.05.003_bib0130","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s10067-014-2730-z","article-title":"Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or RA","volume":"33","author":"Aguila","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rbre.2016.05.003_bib0135","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.semarthrit.2006.07.003","article-title":"Tumor necrosis factor-\u03b1 in inflammatory myopathies: pathophysiology and therapeutic implications","volume":"36","author":"Efthimiou","year":"2006","journal-title":"Semin Arthritis Rheum"}],"container-title":["Revista Brasileira de Reumatologia (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255502116300281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255502116300281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T10:21:36Z","timestamp":1536661296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2255502116300281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S2255502116300281"],"URL":"https:\/\/doi.org\/10.1016\/j.rbre.2016.05.003","relation":{},"ISSN":["2255-5021"],"issn-type":[{"value":"2255-5021","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three cases of anti-TNF induced myositis and literature review","name":"articletitle","label":"Article Title"},{"value":"Revista Brasileira de Reumatologia (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbre.2016.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rbr.2015.12.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}